|
|
|
Corporate Profile: Dicerna Pharmaceuticals
| Summary: |
Dicerna Pharmaceuticals is focused on RNA interference (RNAi) using it proprietary Dicer Substrate Technology™.
|
| Address (HQ): |
480 Arsenal Street
Building 1
Suite 120
Watertown MA 02472 |
| Phone #'s (HQ): |
| Main |
(617) 621-8097 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| DRNA |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
